These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11454473)

  • 1. Design and synthesis of a highly selective EP4-receptor agonist. Part 1: 3,7-dithiaPG derivatives with high selectivity.
    Maruyama T; Asada M; Shiraishi T; Ishida A; Egashira H; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2029-31. PubMed ID: 11454473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9beta-haloPG derivatives with improved stability.
    Maruyama T; Asada M; Shiraishi T; Sakata K; Seki A; Yoshida H; Shinagawa Y; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2033-5. PubMed ID: 11454474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of a highly selective EP2-receptor agonist.
    Tani K; Naganawa A; Ishida A; Egashira H; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2025-8. PubMed ID: 11454472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE(1) and 9-beta-halo derivatives with improved stability.
    Maruyama T; Asada M; Shiraishi T; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jun; 10(6):1743-59. PubMed ID: 11937333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of a selective EP4-receptor agonist. Part 2: 3,7-dithiaPGE1 derivatives with high selectivity.
    Maruyama T; Asada M; Shiraishi T; Ishida A; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):989-1008. PubMed ID: 11836108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a selective EP4-receptor agonist. Part 1: discovery of 3,7-dithiaPGE1 derivatives and identification of their omega chains.
    Maruyama T; Asada M; Shiraishi T; Egashira H; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):975-88. PubMed ID: 11836107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives.
    Tani K; Naganawa A; Ishida A; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):1093-106. PubMed ID: 11836120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
    Hatae N
    Yakugaku Zasshi; 2003 Oct; 123(10):837-43. PubMed ID: 14577329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor.
    Billot X; Chateauneuf A; Chauret N; Denis D; Greig G; Mathieu MC; Metters KM; Slipetz DM; Young RN
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1129-32. PubMed ID: 12643927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist.
    Maruyama T; Kuwabe SI; Kawanaka Y; Shiraishi T; Shinagawa Y; Sakata K; Seki A; Kishida Y; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Hashimoto S; Kawamura M; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jul; 10(7):2103-10. PubMed ID: 11983506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329.
    Nitta M; Hirata I; Toshina K; Murano M; Maemura K; Hamamoto N; Sasaki S; Yamauchi H; Katsu K
    Scand J Immunol; 2002 Jul; 56(1):66-75. PubMed ID: 12100473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization.
    Crider JY; Griffin BW; Sharif NA
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jan; 62(1):21-6. PubMed ID: 10765975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal domain of the human EP4 receptor confers agonist-induced receptor desensitization in a receptor hybrid with the rat EP3beta receptor.
    Neuschäfer-Rube F; Hänecke K; Püschel GP
    FEBS Lett; 1997 Sep; 415(2):119-24. PubMed ID: 9350980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-hydroxy-17,17-trimethylene 9beta-chloro PGF derivatives.
    Tani K; Naganawa A; Ishida A; Egashira H; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):1107-14. PubMed ID: 11836121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.
    Nishigaki N; Negishi M; Ichikawa A
    Mol Pharmacol; 1996 Oct; 50(4):1031-7. PubMed ID: 8863851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid.
    Neuschäfer-Rube F; Oppermann M; Möller U; Böer U; Püschel GP
    Mol Pharmacol; 1999 Aug; 56(2):419-28. PubMed ID: 10419563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype.
    Nishigaki N; Negishi M; Honda A; Sugimoto Y; Namba T; Narumiya S; Ichikawa A
    FEBS Lett; 1995 May; 364(3):339-41. PubMed ID: 7758593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor.
    Bastepe M; Ashby B
    Br J Pharmacol; 1999 Jan; 126(1):365-71. PubMed ID: 10051157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.